Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
NCT07119658
Body Weight, Cardiovascular Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT Number: NCT06635616
known hypertensive patients admitted to emergency department with increased blood pressure will be evaluated in terms of antihypertensive agents given at hospital, degree of blood pressure decrease, hospital stay and laboratory and imaging tests ordered. The impact of routine oral antihypertensive agents used by the patients on these parameter will be assessed.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Etimesgut Military Hospital, Ankara, Turkey (Türkiye)
Hypertensive patients account for approximately 1-25% of annual emergency department visits . While this figure varies by region, hypertensive patients are among the groups that contribute significantly to emergency department crowding and workload . Hypertensive emergencies constitute about 0.3-0.9% of all patients, and this number is rapidly increasing each year .
The 2017 AHA hypertension guidelines emphasize that severe elevations in blood pressure (hypertensive crisis and hypertensive urgency) do not require emergency department visits or referrals unless there is end-organ damage . It is noted that treatment in these patients typically involves dose adjustment or a change in medication .
The 2023 ESC hypertension guidelines recommend that in patients presenting to the emergency department with a hypertensive crisis, blood pressure should be gradually lowered with oral agents over a 24-48 hour period. These patients do not usually require hospital admission but can be monitored in an outpatient setting for clinical evaluation. It is noted that their blood pressure may remain elevated upon discharge from the emergency department, and follow-up in a clinic is necessary for reevaluation of chronic therapy .
Some studies have indicated that both oral and intravenous treatments are preferred for patients presenting with hypertensive crises, highlighting that the approach can vary from physician to physician .
When evaluating literature reviews, published guidelines, and conducted studies, it is observed that there are differences between European and American approaches in defining and treating hypertensive crisis, as well as variability in physician management of these patients .
In our study, we plan to evaluate the effect of emergency department treatment on lowering blood pressure in known hypertensive patients (≥140/80) without end-organ damage. Additionally, we aim to assess the impact of the antihypertensive agents that patients routinely use on their length of stay in the emergency department, as well as the frequency and effectiveness of the medications used, and the target blood pressure values achieved post-treatment according to guidelines.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: from enrollment to the end of follow up duration of 7 days
emergency service blood pressure target achievement duration changes depending on routine oral antihypertensive agent prescribed
Contact information is provided by the study sponsor or research team.
Elif HAMZACEBIOGLU KAYISOGLU, Specialist
CONTACT
Gulsen AKCAY, Ass. Prof.
CONTACT
Saglik Bilimleri Universitesi
Other
Emergency Department Hypertension Management: Effects of Routine Oral Antihypertensive Agents on Emergency Management of Hypertension
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07119658
Body Weight, Cardiovascular Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT07730879
Apnea, Cardiovascular Diseases
Braga, Portugal
View Trial DetailsNCT07719660
Blood Pressure Monitoring, Cardiovascular Diseases
Dresden, Saxony, Germany
View Trial DetailsNCT05459077
Cardiovascular Diseases, HIV-1-infection
Durham, North Carolina, United States
View Trial Details